In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. / Nielsen, Leif K; Green, Trine H; Sandlie, Inger; Michaelsen, Terje E; Dziegiel, Morten Hanefeld.

In: Transfusion, Vol. 48, No. 1, 01.01.2008, p. 12-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Nielsen, LK, Green, TH, Sandlie, I, Michaelsen, TE & Dziegiel, MH 2008, 'In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn', Transfusion, vol. 48, no. 1, pp. 12-9. https://doi.org/10.1111/j.1537-2995.2007.01474.x

APA

Nielsen, L. K., Green, T. H., Sandlie, I., Michaelsen, T. E., & Dziegiel, M. H. (2008). In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. Transfusion, 48(1), 12-9. https://doi.org/10.1111/j.1537-2995.2007.01474.x

Vancouver

Nielsen LK, Green TH, Sandlie I, Michaelsen TE, Dziegiel MH. In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. Transfusion. 2008 Jan 1;48(1):12-9. https://doi.org/10.1111/j.1537-2995.2007.01474.x

Author

Nielsen, Leif K ; Green, Trine H ; Sandlie, Inger ; Michaelsen, Terje E ; Dziegiel, Morten Hanefeld. / In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn. In: Transfusion. 2008 ; Vol. 48, No. 1. pp. 12-9.

Bibtex

@article{d4edbc8fa0fb4137a456105877fa7d65,
title = "In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn",
abstract = "A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of hemolytic maternal anti-D.",
keywords = "Animals, Antibodies, Anti-Idiotypic, Antibody-Dependent Cell Cytotoxicity, CHO Cells, Chemiluminescent Measurements, Cricetinae, Cricetulus, Erythroblastosis, Fetal, Female, Hemolysis, Humans, Immunoglobulin G, Immunotherapy, Monocytes, Mutation, Recombinant Proteins, Respiratory Burst, Rho(D) Immune Globulin",
author = "Nielsen, {Leif K} and Green, {Trine H} and Inger Sandlie and Michaelsen, {Terje E} and Dziegiel, {Morten Hanefeld}",
year = "2008",
month = jan,
day = "1",
doi = "10.1111/j.1537-2995.2007.01474.x",
language = "English",
volume = "48",
pages = "12--9",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "1",

}

RIS

TY - JOUR

T1 - In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn

AU - Nielsen, Leif K

AU - Green, Trine H

AU - Sandlie, Inger

AU - Michaelsen, Terje E

AU - Dziegiel, Morten Hanefeld

PY - 2008/1/1

Y1 - 2008/1/1

N2 - A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of hemolytic maternal anti-D.

AB - A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of hemolytic maternal anti-D.

KW - Animals

KW - Antibodies, Anti-Idiotypic

KW - Antibody-Dependent Cell Cytotoxicity

KW - CHO Cells

KW - Chemiluminescent Measurements

KW - Cricetinae

KW - Cricetulus

KW - Erythroblastosis, Fetal

KW - Female

KW - Hemolysis

KW - Humans

KW - Immunoglobulin G

KW - Immunotherapy

KW - Monocytes

KW - Mutation

KW - Recombinant Proteins

KW - Respiratory Burst

KW - Rho(D) Immune Globulin

U2 - 10.1111/j.1537-2995.2007.01474.x

DO - 10.1111/j.1537-2995.2007.01474.x

M3 - Journal article

C2 - 17764508

VL - 48

SP - 12

EP - 19

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 1

ER -

ID: 35155214